Company data
Enanta Pharmaceuticals, Inc. employees and revenue per employee
ENTA · Biotechnology · $363M market cap
Enanta Pharmaceuticals, Inc. had 120 employees at the end of fiscal Sep 2025, down 8.4% from a year earlier. Revenue for the year was $65.3M, down 3.4% from a year earlier, or $544K per employee. Revenue fell, and headcount fell or held flat with it.
Employees
120
-8.4% YoY
Revenue
$65.3M
-3.4% YoY
Revenue / employee
$544K
Peer median $459K
Rank in industry
50 of 108
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Sep 2025 | 120 | $65.3M | $544K | -8.4% | -3.4% |
| Sep 2024 | 131 | $67.6M | $516K | -9.7% | -14.6% |
| Sep 2023 | 145 | $79.2M | $546K | -9.4% | -8.1% |
| Sep 2022 | 160 | $86.2M | $539K | +3.2% | -11.2% |
| Sep 2021 | 155 | $97.1M | $626K | +9.9% | -20.7% |
| Sep 2020 | 141 | $122M | $869K | +6.8% | -40.3% |
| Sep 2019 | 132 | $205M | $1.55M | +16.8% | -0.7% |
| Sep 2018 | 113 | $207M | $1.83M | +27.0% | +101.0% |
| Sep 2017 | 89 | $103M | $1.16M | +17.1% | +16.5% |
| Sep 2016 | 76 | $88.3M | $1.16M | — | — |
Open roles: we have not matched a verified job board for this company yet.
Enanta Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| ASMB Assembly Biosciences, Inc. | 73 | $72.3M | $990K | Leaner |
| ARCT Arcturus Therapeutics Holdings Inc. | 106 | $67.2M | $634K | Contracting |
| ENTA Enanta Pharmaceuticals, Inc. | 120 | $65.3M | $544K | Contracting |
| TNGX Tango Therapeutics, Inc. | 137 | $62.4M | $455K | Leaner |
| VRDN Viridian Therapeutics, Inc. | 252 | $70.8M | $281K | Efficient growth |
| KURA Kura Oncology, Inc. | 260 | $67.5M | $260K | Hiring ahead |
| NUVB Nuvation Bio Inc. | 298 | $62.9M | $211K | Efficient growth |
| VIR Vir Biotechnology, Inc. | 367 | $68.6M | $187K | Contracting |
| NTLA Intellia Therapeutics, Inc. | 377 | $67.7M | $179K | Leaner |
Questions about Enanta Pharmaceuticals, Inc.
- How many employees does Enanta Pharmaceuticals, Inc. have?
- Enanta Pharmaceuticals, Inc. reported 120 employees for the fiscal year ending Sep 2025, in the annual report it filed on November 19, 2025. That is down 8.4% from a year earlier.
- What is Enanta Pharmaceuticals, Inc.'s revenue per employee?
- Enanta Pharmaceuticals, Inc. brought in $65.3M of revenue in fiscal Sep 2025, which is $544K per employee. That ranks 50 of 108 companies we track in Biotechnology, where the median is $459K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare ENTA with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Enanta Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed November 19, 2025. This is data, not a recommendation to buy or sell ENTA.